BCLSI

Bain Capital Life Sciences Investors Portfolio holdings

AUM $799M
This Quarter Return
+17.32%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$1.77B
AUM Growth
+$1.77B
Cap. Flow
+$46.5M
Cap. Flow %
2.63%
Top 10 Hldgs %
80.46%
Holding
31
New
5
Increased
4
Reduced
1
Closed
–

Top Buys

1
PHVS icon
Pharvaris
PHVS
$89M
2
BLUE
bluebird bio
BLUE
$16.2M
3
SVRA icon
Savara
SVRA
$13.5M
4
RACB
Research Alliance Corp. II Class A Common Stock
RACB
$10.3M
5
ARYD
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$7.33M

Top Sells

1
SWTX
SpringWorks Therapeutics
SWTX
$107M

Sector Composition

1 Healthcare 92.43%
2 Financials 1.68%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
SWTX
1
DELISTED
SpringWorks Therapeutics
SWTX
$429M 24.3% 5,831,307 -1,450,000 -20% -$107M
AVIR icon
2
Atea Pharmaceuticals
AVIR
$267M
$347M 19.64% 5,615,659 – –
ARQT icon
3
Arcutis Biotherapeutics
ARQT
$1.86B
$115M 6.52% 3,979,292 – –
DVAX icon
4
Dynavax Technologies
DVAX
$1.19B
$107M 6.07% 10,895,773 – –
ANNX icon
5
Annexon
ANNX
$226M
$90.2M 5.11% 3,241,628 – –
PHVS icon
6
Pharvaris
PHVS
$1.39B
$89M 5.04% +3,180,601 New +$89M
DRNA
7
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$78.8M 4.46% 3,080,237 – –
CCCC icon
8
C4 Therapeutics
CCCC
$185M
$60.7M 3.44% 1,642,209 – –
MRSN icon
9
Mersana Therapeutics
MRSN
$36.5M
$59.8M 3.39% 3,695,667 +250,000 +7% +$4.05M
SLDB icon
10
Solid Biosciences
SLDB
$427M
$43.9M 2.48% 7,929,918 +869,565 +12% +$4.81M
SYRS
11
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$43.3M 2.45% 5,785,036 – –
NRIX icon
12
Nurix Therapeutics
NRIX
$714M
$39.9M 2.26% 1,284,314 – –
CNST
13
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$32.7M 1.86% 1,400,000 – –
APTX
14
DELISTED
Aptinyx Inc. Common Stock
APTX
$26.7M 1.51% 8,891,758 – –
SVRA icon
15
Savara
SVRA
$567M
$24.2M 1.37% 11,622,598 +6,494,005 +127% +$13.5M
MRNS
16
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$22.2M 1.25% 1,431,058 – –
SYRE icon
17
Spyre Therapeutics
SYRE
$996M
$21.4M 1.21% 2,700,000 – –
KYMR icon
18
Kymera Therapeutics
KYMR
$2.95B
$18.6M 1.06% 479,605 – –
XFOR icon
19
X4 Pharmaceuticals
XFOR
$84.3M
$18.2M 1.03% 2,119,540 +471,055 +29% +$4.06M
CRNX icon
20
Crinetics Pharmaceuticals
CRNX
$2.92B
$16.4M 0.93% 1,071,428 – –
BLUE
21
DELISTED
bluebird bio
BLUE
$16.2M 0.92% +538,179 New +$16.2M
NAUT icon
22
Nautilus Biotechnolgy
NAUT
$85.9M
$13.8M 0.78% 1,000,000 – –
PNT
23
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
$10.5M 0.6% 1,000,000 – –
RACB
24
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$10.3M 0.58% +1,000,000 New +$10.3M
ARYD
25
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$7.33M 0.42% +700,000 New +$7.33M
1
2